BlackRock’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102K | Buy |
|
|||||
|
2025
Q1 | $221K | Sell |
|
|||||
|
2024
Q4 | $266K | Hold |
|
|||||
|
2024
Q3 | $512K | Sell |
|
|||||
|
2024
Q2 | $459K | Sell |
|
|||||
|
2024
Q1 | $2.56M | Sell |
|
|||||
|
2023
Q4 | $2.4M | Sell |
|
|||||
|
2023
Q3 | $8.27M | Buy |
|
|||||
|
2023
Q2 | $11.3M | Buy |
|
|||||
|
2023
Q1 | $10.5M | Sell |
|
|||||
|
2022
Q4 | $14.5M | Buy |
|
|||||
|
2022
Q3 | $21M | Buy |
|
|||||
|
2022
Q2 | $9.67M | Buy |
|
|||||
|
2022
Q1 | $15.1M | Buy |
|
|||||
|
2021
Q4 | $28.1M | Buy |
|
|||||
|
2021
Q3 | $45.4M | Buy |
|
|||||
|
2021
Q2 | $34.5M | Sell |
|
|||||
|
2021
Q1 | $55.5M | Buy |
|
|||||
|
2020
Q4 | $69.8M | Buy |
|
|||||
|
2020
Q3 | $32.2M | Buy |
|